ConductScience.org, home

Paper36980630

Overview of Trop-2 in Cancer: From Pre-Clinical Studies to Future Directions in Clinical Settings.

Lombardi P and 9 others. Cancers (Basel), 2023. Cited by 56 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Overview of Trop-2 in Cancer: From Pre-Clinical Studies to Future Directions in Clinical Settings. Papers, record 36980630. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36980630

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Overview of Trop-2 in Cancer: From Pre-Clinical Studies to Future Directions in Clinical Settings.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
56
iCite
Relative citation ratio, by iCite
4.87
iCite
Revised in PubMed
2024-09-15
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lombardi PPasquale
2Filetti MMarcohttps://orcid.org/0000-0002-4734-7541
3Falcone RRosahttps://orcid.org/0000-0001-9679-4711
4Altamura VValeria
5Paroni Sterbini FFrancesco
6Bria EEmilio
7Fabi AAlessandrahttps://orcid.org/0000-0002-6320-2609
8Giannarelli DDiana
9Scambia GGiovanni
10Daniele GGennarohttps://orcid.org/0000-0001-5360-1895

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
NAGilead Sciences (Italy)PubMed

Source PubMed

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT07343453A Single-Arm, Phase II Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan in Second-Line and Subsequent Treatments for Advanced Thymic Epithelial TumorsBackground

Source ClinicalTrials.gov

Download CSV of trials

References75

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128709407Trop2 enhances invasion of thyroid cancer by inducing MMP2 through ERK and JNK pathways.BMC Cancer2017https://conductscience.org/library/papers/28709407PubMed
226000093Trop2 and its overexpression in cancers: regulation and clinical/therapeutic implications.Genes Cancer2015https://conductscience.org/library/papers/26000093PubMed
318930986TROP2 expression as prognostic marker for gastric carcinoma.J Clin Pathol2009https://conductscience.org/library/papers/18930986PubMed
419429791Potential hepatic stem cells reside in EpCAM+ cells of normal and injured mouse liver.Development2009https://conductscience.org/library/papers/19429791PubMed
525431858Discovery of cytotoxic dolastatin 10 analogues with N-terminal modifications.J Med Chem2014https://conductscience.org/library/papers/25431858PubMed
627582525RN927C, a Site-Specific Trop-2 Antibody-Drug Conjugate (ADC) with Enhanced Stability, Is Highly Efficacious in Preclinical Solid Tumor Models.Mol Cancer Ther2016https://conductscience.org/library/papers/27582525PubMed
721970857Loss of Trop2 promotes carcinogenesis and features of epithelial to mesenchymal transition in squamous cell carcinoma.Mol Cancer Res2011https://conductscience.org/library/papers/21970857PubMed
87029529Human trophoblast cell-surface antigens defined by monoclonal antibodies.Proc Natl Acad Sci U S A1981https://conductscience.org/library/papers/7029529PubMed
92395876Molecular cloning of cDNA for the human tumor-associated antigen CO-029 and identification of related transmembrane antigens.Proc Natl Acad Sci U S A1990https://conductscience.org/library/papers/2395876PubMed
1026106073Enhanced Delivery of SN-38 to Human Tumor Xenografts with an Anti-Trop-2-SN-38 Antibody Conjugate (Sacituzumab Govitecan).Clin Cancer Res2015https://conductscience.org/library/papers/26106073PubMed
1121551320Expression of Trop2 cell surface glycoprotein in normal and tumor tissues: potential implications as a cancer therapeutic target.J Histochem Cytochem2011https://conductscience.org/library/papers/21551320PubMed
1228548889Therapy of Advanced Non-Small-Cell Lung Cancer With an SN-38-Anti-Trop-2 Drug Conjugate, Sacituzumab Govitecan.J Clin Oncol2017https://conductscience.org/library/papers/28548889PubMed
1310328271HIKE, a candidate protein binding site for PH domains, is a major regulatory region of Gbeta proteins.Proteins1999https://conductscience.org/library/papers/10328271PubMed
1427022065Trop-2 Induces Tumor Growth Through AKT and Determines Sensitivity to AKT Inhibitors.Clin Cancer Res2016https://conductscience.org/library/papers/27022065PubMed
1516552761Control of cell migration in the zebrafish lateral line: implication of the gene "tumour-associated calcium signal transducer," tacstd.Dev Dyn2006https://conductscience.org/library/papers/16552761PubMed
1629276405Prognostic role and clinical significance of trophoblast cell surface antigen 2 in various carcinomas.Cancer Manag Res2017https://conductscience.org/library/papers/29276405PubMed
1734519889ImmunoPET of trophoblast cell-surface antigen 2 (Trop-2) expression in pancreatic cancer.Eur J Nucl Med Mol Imaging2022https://conductscience.org/library/papers/34519889PubMed
1825523132Trop2: from development to disease.Dev Dyn2015https://conductscience.org/library/papers/25523132PubMed
1926015409Trop-2 is up-regulated in invasive prostate cancer and displaces FAK from focal contacts.Oncotarget2015https://conductscience.org/library/papers/26015409PubMed
2022562244The Trop-2 signalling network in cancer growth.Oncogene2013https://conductscience.org/library/papers/22562244PubMed

See all 75 referencesDownload CSV of references

Cited by42

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 56 citations.

PMIDTitleJournalYearIn PapersSource
42729864Structure and function of therapeutic antibodies approved by the US FDA in 2025.Antib Ther2026https://conductscience.org/library/papers/42729864PubMed
42656367Adipocyte-derived estrogen signaling influences TROP2 expression in ERα-positive breast cancer.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42656367PubMed
42653691Antibody-Drug Conjugates Targeting HER2 and Trop-2: A New Force in Precision Treatment for Solid Tumors.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42653691PubMed
42482759Datopotamab deruxtecan in solid tumors: Recent research progress and clinical applications.Front Oncol2026https://conductscience.org/library/papers/42482759PubMed
42375351Antibody-drug conjugates in gynecologic malignancies: breakthroughs, challenges, and future directions.Front Immunol2026https://conductscience.org/library/papers/42375351PubMed
42352327A Pyrone Glucoside from Maerua angolensis Induces Caspase-Dependent Apoptosis and Targets AKT1, PARP-1, and Caspase-7 in Triple-Negative Breast Cancer.Biomolecules2026https://conductscience.org/library/papers/42352327PubMed
42297906Pan-cancer multi-omic integration of Trop2 reveals biological determinants and translational implications for ADC therapy.NPJ Precis Oncol2026https://conductscience.org/library/papers/42297906PubMed
42294312Trop-2 expression is associated with poor survival in pleural mesothelioma.Front Oncol2026https://conductscience.org/library/papers/42294312PubMed
42142358TROPION-Urothelial03: a phase II/III study of datopotamab deruxtecan (Dato-DXd) for locally advanced or metastatic urothelial carcinoma.Future Oncol2026https://conductscience.org/library/papers/42142358PubMed
41900872Receptor-Mediated Drug Delivery: Redefining Targeted Drug Conjugates in Oncology.Pharmaceutics2026https://conductscience.org/library/papers/41900872PubMed
41867620Exploring Trop-2-Nanobody PPI Interactions through Molecular Dynamics Simulations and Biovalidations.ACS Omega2026https://conductscience.org/library/papers/41867620PubMed
41621018Clinical advances and challenges of antibody-mediated targeted drug delivery in breast cancer therapeutics.Discov Oncol2026https://conductscience.org/library/papers/41621018PubMed
41613789A Holistic Review of Oncological Drug Targets and Trajectories of Resistance in Cancer Therapy.Oncol Res2026https://conductscience.org/library/papers/41613789PubMed
41533296Prognostic impact of TROP2 in adenocarcinoma of the esophageal junction and stomach.Clin Transl Oncol2026https://conductscience.org/library/papers/41533296PubMed
41427810Predictive Biomarkers of Antibody-Drug Conjugate Efficacy for Solid Tumors: Current Challenges and the Potential Role of Quantitative Proteomics.Clin Cancer Res2026https://conductscience.org/library/papers/41427810PubMed
41426858Diagnostic Significance of Trophoblast Cell Surface Antigen-2 Expression in Benign and Malignant Thyroid Lesions.Cureus2025https://conductscience.org/library/papers/41426858PubMed
41286743Real-world insights into the prevalence and prognostic significance of trophoblast cell-surface antigen 2 and folate receptor alpha in uterine carcinosarcoma.BMC Cancer2025https://conductscience.org/library/papers/41286743PubMed
41280245Trop2 expression, p16 expression status, and histologic subtype in carcinoma of the uterine cervix.Pathol Oncol Res2025https://conductscience.org/library/papers/41280245PubMed
41272532Establishment of a new method for detection of TROP2-positive circulating tumor cells in breast cancer.BMC Cancer2025https://conductscience.org/library/papers/41272532PubMed
41014400
Baseline hemoglobin and neutrophil-to-lymphocyte ratio as prognostic biomarkers in patients with metastatic triple negative breast cancer treated with sacituzumab govitecan in second line and beyond: a real-world analysis.
Breast Cancer Res Treat2025https://conductscience.org/library/papers/41014400PubMed

See all 42 cited byDownload CSV of cited by

Genes33

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
ALK238PubTator's text mininghttps://conductscience.org/library/genes/238NCBI Gene
AREG374PubTator's text mininghttps://conductscience.org/library/genes/374NCBI Gene
CCND1595PubTator's text mininghttps://conductscience.org/library/genes/595NCBI Gene
CDH1999PubTator's text mininghttps://conductscience.org/library/genes/999NCBI Gene
CREB11385PubTator's text mininghttps://conductscience.org/library/genes/1385NCBI Gene
CTSS1520PubTator's text mininghttps://conductscience.org/library/genes/1520NCBI Gene
EGF1950PubTator's text mininghttps://conductscience.org/library/genes/1950NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
EPCAM4072PubTator's text mininghttps://conductscience.org/library/genes/4072NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
ERBB32065PubTator's text mininghttps://conductscience.org/library/genes/2065NCBI Gene
IGF13479PubTator's text mininghttps://conductscience.org/library/genes/3479NCBI Gene
IGF1R3480PubTator's text mininghttps://conductscience.org/library/genes/3480NCBI Gene
JUN3725PubTator's text mininghttps://conductscience.org/library/genes/3725NCBI Gene
MAP2K75609PubTator's text mininghttps://conductscience.org/library/genes/5609NCBI Gene
MAPK15594PubTator's text mininghttps://conductscience.org/library/genes/5594NCBI Gene
MYC4609PubTator's text mininghttps://conductscience.org/library/genes/4609NCBI Gene
NFKB14790PubTator's text mininghttps://conductscience.org/library/genes/4790NCBI Gene
NOS24843PubTator's text mininghttps://conductscience.org/library/genes/4843NCBI Gene

See all 33 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36980630

GET https://conductscience.org/api/papers/v1/36980630/references?page=2